Products

China Urolithin A Diacetate supplier Manufacturer, Supplier, Factory

Superpharma Group is a professional Urolithin A Diacetate supplier manufacturer and supplier in China. Welcome to import quality products from our factory here.

Hot Products

  • Dapoxetine

    Dapoxetine

    Model:CAS No. 119356-77-3

    Quality standards:USP、IP

    Superpharma Group supports bulk purchase and sourcing of Dapoxetine API within anabolic / androgen / steroids–related product categories for global buyers. As an experienced China manufacturer and distributor, we focus on compliant API raw material procurement for pharmaceutical companies and professional distributors worldwide.
  • Sildenafil

    Sildenafil

    Model:CAS No. 171599-83-0

    Quality standards:USP、IP

    Superpharma Group supports bulk procurement and sourcing of Sildenafil API within anabolic / androgen / steroids–related product categories for global B2B buyers. As an experienced China manufacturer and distributor, we focus on compliant API raw materials supply for pharmaceutical and healthcare companies worldwide.
  • Liraglutide

    Liraglutide

    Model:CAS No. 204656-20-2

    Quality standards:USP、IP

    Superpharma Group supports bulk purchase and sourcing of Liraglutide API within Peptides / GLP-1 products categories for global buyers. As a professional China manufacturer and distributor, we focus on compliant API raw materials supply for pharmaceutical companies and qualified distributors worldwide.
  • Oxandrolone

    Oxandrolone

    Model:CAS NO.53-39-4

    Quality standards:USP、IP

    Oxandrolone/Anavar from Superpharma Group is a USP-grade oral anabolic steroid API known for its mild profile and high anabolic efficiency. Produced under GMP standards, our Oxandrolone offers excellent purity, formulation stability, and reliable bulk buy supply for global pharmaceutical and brand customers.

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy
RejectAccept